<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>1981 (9) TMI 285 - GOVERNMENT OF INDIA</title>
    <link>https://www.taxtmi.com/caselaws?id=165824</link>
    <description>Aniline, para nitro chloro benzene and acetanilide were treated as eligible drug-intermediates under the exemption notification where they were actually used in the manufacture of drugs. The narrower view that a drug-intermediate must be predominantly used for drugs or must represent the penultimate stage of manufacture was rejected because the notification did not impose those limits. Since the goods had other uses, the exemption depended on end-use verification and proof of actual use to the satisfaction of the authority. The appellate order was set aside, and exemption was confined to the extent of proven use in drug manufacture.</description>
    <language>en-us</language>
    <pubDate>Mon, 14 Sep 1981 00:00:00 +0530</pubDate>
    <lastBuildDate>Tue, 12 Aug 2014 18:50:01 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=362199" rel="self" type="application/rss+xml"/>
    <item>
      <title>1981 (9) TMI 285 - GOVERNMENT OF INDIA</title>
      <link>https://www.taxtmi.com/caselaws?id=165824</link>
      <description>Aniline, para nitro chloro benzene and acetanilide were treated as eligible drug-intermediates under the exemption notification where they were actually used in the manufacture of drugs. The narrower view that a drug-intermediate must be predominantly used for drugs or must represent the penultimate stage of manufacture was rejected because the notification did not impose those limits. Since the goods had other uses, the exemption depended on end-use verification and proof of actual use to the satisfaction of the authority. The appellate order was set aside, and exemption was confined to the extent of proven use in drug manufacture.</description>
      <category>Case-Laws</category>
      <law>Central Excise</law>
      <pubDate>Mon, 14 Sep 1981 00:00:00 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/caselaws?id=165824</guid>
    </item>
  </channel>
</rss>